These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6151958)

  • 1. Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
    Ansseau M; Ansoms C; Beckers G; Bogaerts M; Botte L; De Buck R; Diricq S; Dumortier A; Jansegers E; Owieczka J
    J Affect Disord; 1984 Dec; 7(3-4):287-96. PubMed ID: 6151958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
    Rickels K; Feighner JP; Smith WT
    Arch Gen Psychiatry; 1985 Feb; 42(2):134-41. PubMed ID: 2858187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression.
    Feighner JP
    Mod Probl Pharmacopsychiatry; 1982; 18():196-212. PubMed ID: 6124883
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J; Schless AP
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
    Feighner JP; Meredith CH; Frost NR; Chammas S; Hendrickson G
    Acta Psychiatr Scand; 1983 Oct; 68(4):223-33. PubMed ID: 6138925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
    Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
    Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):37S-43S. PubMed ID: 2859877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case report of alprazolam-induced stuttering.
    Elliott RL; Thomas BJ
    J Clin Psychopharmacol; 1985 Jun; 5(3):159-60. PubMed ID: 2860135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alprazolam in clinically anxious patients with depressed mood.
    Aden GC
    J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.
    Feighner J; Hendrickson G; Miller L; Stern W
    J Clin Psychopharmacol; 1986 Feb; 6(1):27-32. PubMed ID: 3081600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Psychopharmacology (Berl); 1983; 80(4):308-10. PubMed ID: 6137856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
    Lenox RH; Shipley JE; Peyser JM; Williams JM; Weaver LA
    Psychopharmacol Bull; 1984; 20(1):79-82. PubMed ID: 6144136
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of alprazolam, imipramine, and placebo in the treatment of depression.
    Feighner JP; Aden GC; Fabre LF; Rickels K; Smith WT
    JAMA; 1983 Jun; 249(22):3057-64. PubMed ID: 6133970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety.
    Greiss KC; Fogari R
    J Clin Pharmacol; 1980; 20(11):693-9. PubMed ID: 6112245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
    Dawson GW; Jue SG; Brogden RN
    Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression.
    Imlah NW
    Br J Psychiatry; 1985 May; 146():515-9. PubMed ID: 2861873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study.
    Chouinard G; Annable L; Fontaine R; Solyom L
    Psychopharmacology (Berl); 1982; 77(3):229-33. PubMed ID: 6126907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam (Xanax, the Upjohn Company).
    Evans RL
    Drug Intell Clin Pharm; 1981 Sep; 15(9):633-8. PubMed ID: 6115742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term comparison of alprazolam, lorazepam and placebo in patients with an anxiety disorder.
    Cohn JB; Wilcox CS
    Pharmacotherapy; 1984; 4(2):93-8. PubMed ID: 6144090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.